QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
NASDAQ:ATRA

Atara Biotherapeutics - ATRA News Today

$5.46
+0.33 (+6.43%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$5.20
$5.54
50-Day Range
$2.85
$5.46
52-Week Range
$2.83
$16.07
Volume
913,883 shs
Average Volume
1.08 million shs
Market Capitalization
$518.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.63
Get Atara Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRA and its competitors with MarketBeat's FREE daily newsletter.



ATRA Media Mentions By Week

ATRA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATRA
News Sentiment

0.53

0.45

Average
Medical
News Sentiment

ATRA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATRA Articles
This Week

2

2

ATRA Articles
Average Week

SourceHeadline
marketbeat.com logoRaymond James & Associates Has $697,000 Position in Atara Biotherapeutics, Inc. (NASDAQ:ATRA)
marketbeat.com - January 31 at 4:13 AM
MarketBeat logoBrokerages Set Atara Biotherapeutics, Inc. (NASDAQ:ATRA) PT at $19.50
americanbankingnews.com - January 28 at 3:40 AM
finance.yahoo.com logoAtara Biotherapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 6:46 PM
finance.yahoo.com logoAtara Biotherapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 6:46 PM
marketwatch.com logoAtara Biotherapeutics Gets $31M Royalty Interest Financing Deal, Shares Rise 6%
marketwatch.com - December 20 at 7:40 PM
finance.yahoo.com logoAtara Biotherapeutics Announces $31 Million Royalty Interest Financing Agreement with HealthCare Royalty
finance.yahoo.com - December 20 at 7:40 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Madrigal Pharmaceuticals (MDGL) and Atara Biotherapeutics (ATRA)
markets.businessinsider.com - December 19 at 1:16 PM
benzinga.com logoAtara Biotherapeutics' Ebvallo™ (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD
benzinga.com - December 19 at 8:16 AM
markets.businessinsider.com logoAtara's Ebvallo Receives European Commission Approval For Adults And Children With EBV+ PTLD
markets.businessinsider.com - December 19 at 8:16 AM
finance.yahoo.com logoAtara Biotherapeutics’ Ebvallo™ (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD
finance.yahoo.com - December 19 at 8:16 AM
finance.yahoo.com logoAtara Biotherapeutics Announces Changes to Its Board of Directors
finance.yahoo.com - December 19 at 8:16 AM
seekingalpha.com logoConsider Atara Biotherapeutics As The Tab-Cel Delay Resolves In The U.S.
seekingalpha.com - December 17 at 8:20 AM
finance.yahoo.com logoAtara Biotherapeutics Presents Updated Clinical Data from Pivotal Phase 3 Trial (ALLELE) of Tab-cel® at the 64th American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - December 12 at 3:57 PM
finance.yahoo.com logoAtara Biotherapeutics to Participate at the Evercore ISI 5th Annual HealthCONx Conference
finance.yahoo.com - November 23 at 8:57 AM
finance.yahoo.com logoNewsflash: Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Analysts Have Been Trimming Their Revenue Forecasts
finance.yahoo.com - November 22 at 5:39 AM
finance.yahoo.com logoAtara Biotherapeutics Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS In Line
finance.yahoo.com - November 10 at 6:46 AM
finance.yahoo.com logoAtara Biotherapeutics to Participate at the Stifel Healthcare Conference
finance.yahoo.com - November 9 at 7:51 PM
markets.businessinsider.com logoMizuho Securities Keeps Their Buy Rating on Atara Biotherapeutics (ATRA)
markets.businessinsider.com - November 8 at 11:30 PM
finance.yahoo.com logoAtara Biotherapeutics Announces Third Quarter 2022 Financial Results and Operational Progress
finance.yahoo.com - November 8 at 6:29 PM
msn.com logoAtara Biotherapeutics's Earnings: A Preview
msn.com - November 7 at 2:57 PM
finance.yahoo.com logoAtara Biotherapeutics to Announce Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
finance.yahoo.com - November 1 at 4:50 PM
finance.yahoo.com logoAtara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2022
finance.yahoo.com - October 26 at 4:02 AM
finance.yahoo.com logoCHMP Recommends Approval of Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease
finance.yahoo.com - October 14 at 7:58 AM
finance.yahoo.com logoAtara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - October 10 at 5:52 PM
finance.yahoo.com logoAllogene (ALLO) Begins Phase II Study on Allogeneic CAR T Therapy
finance.yahoo.com - October 7 at 12:30 PM
finance.yahoo.com logoAcadia (ACAD) Rises More Than 14% in 3 Months: Here's Why
finance.yahoo.com - October 6 at 4:05 PM
seekingalpha.com logoATRA Atara Biotherapeutics, Inc.
seekingalpha.com - October 1 at 3:04 PM
finance.yahoo.com logoHorizon (HZNP) Completes Enrollment in Phase IV TED Study
finance.yahoo.com - September 30 at 11:07 AM
markets.businessinsider.com logoAtara Biotherapeutics to Receive Additional Near-Term Milestone Under Updated Tab-cel Commercialization Pact
markets.businessinsider.com - September 29 at 8:11 AM
finance.yahoo.com logoAtara Biotherapeutics to Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel (Tab-cel®) Commercialization Agreement with Pierre Fabre
finance.yahoo.com - September 28 at 7:19 PM
finance.yahoo.com logoEmergent (EBS) Acquires Worldwide Rights to Smallpox Antiviral
finance.yahoo.com - September 27 at 12:58 PM
finance.yahoo.com logoAtara Biotherapeutics, Inc. (ATRA)
finance.yahoo.com - September 19 at 8:02 PM
finance.yahoo.com logoAtara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Citigroup 17th Annual Biopharma Conference
finance.yahoo.com - August 31 at 4:48 PM
finance.yahoo.com logoAeglea (AGLE) Down on Corporate Restructuring, CEO Steps Down
finance.yahoo.com - August 25 at 4:59 PM
finance.yahoo.com logoLayoffs continue as biotech companies look to rein in downturn-era costs
finance.yahoo.com - August 24 at 8:49 PM
finance.yahoo.com logoHorizon (HZNP) Marketed Drugs Aid Growth, Stiff Rivalry a Woe
finance.yahoo.com - August 23 at 3:38 PM
seekingalpha.com logoAtara: 2 Possible Regulatory Approvals For Tab-Cel, Plus CAR T Pipeline
seekingalpha.com - August 17 at 4:15 PM
finance.yahoo.com logoDoes Atara Biotherapeutics (ATRA) Have the Potential to Rally 204% as Wall Street Analysts Expect?
finance.yahoo.com - August 15 at 9:55 PM
finance.yahoo.com logoAtara Lays Off 20% Of Its Workforce, Issues Update On Cell Therapies
finance.yahoo.com - August 9 at 6:29 PM
seekingalpha.com logoAtara stock rises ~27% on Q2 beat, US regulatory path for tab-cel; to cut 20% staff
seekingalpha.com - August 9 at 4:43 PM
seekingalpha.com logoAtara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 10:25 PM
finance.yahoo.com logoAtara Biotherapeutics (ATRA) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 8 at 10:25 PM
finance.yahoo.com logoAtara Biotherapeutics Announces Second Quarter 2022 Financial Results and Corporate Strategy Update
finance.yahoo.com - August 8 at 5:13 PM
apnews.com logoBragar Eagel & Squire, P.C. Is Investigating TuSimple, Atara, Mercury, and the WWE and Encourages Investors to Contact the Firm
apnews.com - August 5 at 11:22 PM
finance.yahoo.com logoAtara Biotherapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
finance.yahoo.com - August 3 at 8:39 PM
finance.yahoo.com logoHorizon (HZNP) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
finance.yahoo.com - August 3 at 3:38 PM
finance.yahoo.com logoAfter Plunging 65.7% in 4 Weeks, Here's Why the Trend Might Reverse for Atara Biotherapeutics (ATRA)
finance.yahoo.com - August 2 at 12:49 PM
finance.yahoo.com logoAtara Biotherapeutics to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
finance.yahoo.com - August 1 at 4:13 PM
finance.yahoo.com logoDr. Reddy's (RDY) Q1 Earnings Increase Y/Y, Sales Increase
finance.yahoo.com - July 29 at 7:20 PM
apnews.com logoINVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Atara Biotherapeutics, Inc. with Losses of $100,000 to Contact the Firm
apnews.com - July 28 at 6:08 PM
finance.yahoo.com logoWhy Atara Biotherapeutics Stock Is Crashing Today
finance.yahoo.com - July 13 at 5:35 PM
Get Atara Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRA and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ATRA) was last updated on 2/2/2023 by MarketBeat.com Staff